Recursion Pharmaceuticals Inc (RXRX) — Capital Reinvestment Ratio
Latest as of March 2022:
0.06x
Recursion Pharmaceuticals Inc (RXRX) has a Capital Reinvestment Ratio of 0.06x as of March 2022, meaning it reinvests 0% of its operating cash flow ($77.39 Million) in capital expenditures ($4.34 Million). See free cash flow generation of Recursion Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
$77.39 Million
USD
Capital Expenditures
$4.34 Million
USD
Data as of
Mar 2022
Most recent filing
Annual Capital Reinvestment Ratio for Recursion Pharmaceuticals Inc (None–None)
Year-by-year Capital Reinvestment Ratio for Recursion Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see RXRX company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow